IA
PGEN icon

Intellus Advisors’s Precigen PGEN Stock Holding History

Intellus Advisors’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$90.5K Hold
15,870
– – 0.01% 133
2026
Q1 		$61.4K Hold
15,870
– – 0.01% 125
2025
Q4 		$66.3K Hold
15,870
– – 0.01% 134
2025
Q3 		$52.2K Hold
15,870
– – 0.01% 134
2025
Q2 		$22.5K Buy
+15,870
New +$22.6K ﹤0.01% 135
2025
Q1 		– Sell
-15,870
Closed -$17.8K – 128
2024
Q4 		$17.8K Buy
+15,870
New +$13.5K ﹤0.01% 118

Other funds holding PGEN

PCM
Patient Capital Management Baltimore, Maryland $3.05B AUM 42.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Intellus Advisors's PGEN Position: Q2 2026 in Review

Intellus Advisors held its Precigen (PGEN) position steady in Q2 2026 at 15,870 shares worth $90.5K. The position accounts for 0.01% of the portfolio, ranked #133.

Intellus Advisors first reported a position in PGEN in Q4 2024 and has held it in 6 quarters since. 211 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • Intellus Advisors held 15,870 shares of Precigen worth $90.5K as of Q2 2026.
  • Intellus Advisors left its Precigen share count unchanged in Q2 2026.
  • Precigen made up 0.01% of Intellus Advisors's portfolio in Q2 2026, its #133 holding.
  • Intellus Advisors first reported a position in Precigen in Q4 2024 and has held it in 6 quarters since.
  • 211 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Intellus Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.